Report: Mylan Could See Sweetened Bid From Teva Pharmaceutical

By: via Benzinga
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) will soon sweeten its $40 billion bid for Netherlands-based Mylan Inc (NASDAQ: MYL) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.